{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T13:47:38Z","timestamp":1697550458219},"reference-count":16,"publisher":"Wiley","issue":"s13","license":[{"start":{"date-parts":[[2002,1,5]],"date-time":"2002-01-05T00:00:00Z","timestamp":1010188800000},"content-version":"vor","delay-in-days":461,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Allergy Immunology"],"published-print":{"date-parts":[[2000,10]]},"abstract":"<jats:p>Despite the development of many new therapies for the treatment of asthma, the prevalence of this disease is still increasing in many areas of the world. Today no intervention is able to completely cure asthma but chronic therapies could decrease its severity. Moreover, asthma is one of the most common chronic diseases of childhood and its pharmacoeconomic burden is huge. Epidemiologic studies have identified some of the major factors involved in the pathogenesis and evolution of asthma. Several prevention programs have been developed in different countries with various success rates. Most of those interventions were based on allergen avoidance. From studies aimed at controlling early asthma and from epidemiologic data, we have learned to identify high\u2010risk groups, e.g, the atopic child with allergic asthma, with a family history of asthma or allergy\u2010related disease and early sensitization to aeroallergens. Only a few prospective studies aimed at preventing the onset of asthma have been published. With ketotifen, Iikura et\u00a0al. could prevent the onset of asthma after a 1\u2010year period in patients suffering from atopic dermatitis. Another study has been published by Bustos et\u00a0al. concerning children with a family history of allergy and high total IgE levels. Those studies involved about 100 patients. No follow\u2010up data has been published for either of them. Recently, the first results from the ETAC<jats:sup>\u00ae<\/jats:sup> (Early Treatment of the Atopic Child) trial have been reported. This study involved 817 atopic children with atopic dermatitis and a family history of atopy: cetirizine halved the number of patients developing asthma in the subgroups (200 children) sensitized to house dust mite (51.5% versus 28.6%) or pollen (58.8% versus 27.8%). The optimal target for pharmaceutical intervention to prevent asthma would seem to be high risk patients: children with atopic dermatitis, a family history of asthma or atopic disease and early sensitization to aeroallergens. Primary prevention in whole populations (e.g. starting even before the onset of atopic dermatitis or allergen sensitization) does not at present appear to be a realistic approach.<\/jats:p>","DOI":"10.1034\/j.1399-3038.2000.00510.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T16:00:39Z","timestamp":1047484839000},"page":"41-44","source":"Crossref","is-referenced-by-count":7,"title":["What are the candidate groups for pharmacotherapeutic intervention to\u2028prevent asthma?"],"prefix":"10.1111","volume":"11","author":[{"given":"M.","family":"De Longueville","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,5]]},"reference":[{"key":"e_1_2_7_2_2","unstructured":"European Allergy White Paper UCB Institute of Allergy 1997."},{"key":"e_1_2_7_3_2","unstructured":"Worldwide variation in prevalence of symptoms of asthma allergic rhinoconjunctivitis and atopic eczema: ISAAC.Lancet1998;11:12251232."},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199501193320301"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807163390302"},{"key":"e_1_2_7_6_2","first-page":"400","article-title":"Risk factors in early childhood for the development of atopic diseases","volume":"49","author":"Bj\u00f6rksten B","year":"1994","journal-title":"Acta Psychiatr Scand"},{"key":"e_1_2_7_7_2","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1365-2222.1997.tb01168.x","article-title":"The development of allergy in high\u2010risk children","volume":"27","author":"Burr ML","year":"1997","journal-title":"Clin Exp Allergy"},{"issue":"10","key":"e_1_2_7_8_2","first-page":"16","article-title":"The natural course of sensitisation and atopic disease in infancy and childhood","volume":"8","author":"Wahn U","year":"1997","journal-title":"Pediatr Allergy Immunol"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)90031-3"},{"key":"e_1_2_7_10_2","first-page":"89","article-title":"Allergen avoidance in infancy and allergy at 4 years of age","volume":"51","author":"Hide DW","year":"1996","journal-title":"Acta Psychiatr Scand"},{"key":"e_1_2_7_11_2","first-page":"1","article-title":"Internation\u2010al Consensus report on diagnosis and management of asthma","volume":"47","author":"International Asthma Management Project","year":"1992","journal-title":"Allergy"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.67.2.240"},{"key":"e_1_2_7_13_2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0011-393X(98)85097-2","article-title":"Prophylactic treatment with loratadine versus cromolyn sodium in children with mild to moderate perennial asthma","volume":"8","author":"Menardo JL","year":"1998","journal-title":"Curr Ther Res"},{"key":"e_1_2_7_14_2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0091-6749(96)70307-X","article-title":"Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis. J","volume":"97","author":"Meltzer EO","year":"1996","journal-title":"Allergy Clin Immunol"},{"key":"e_1_2_7_15_2","first-page":"233","article-title":"Prevention of asthma by ketotifen in infants with atopic dermatitis","volume":"68","author":"Iikura Y","year":"1992","journal-title":"Ann Allergy"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1995.tb01096.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.1998.tb00356.x"}],"container-title":["Pediatric Allergy and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-3038.2000.00510.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-3038.2000.00510.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1399-3038.2000.00510.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T22:31:06Z","timestamp":1695767466000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1399-3038.2000.00510.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":16,"journal-issue":{"issue":"s13","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["10.1034\/j.1399-3038.2000.00510.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1399-3038.2000.00510.x","archive":["Portico"],"relation":{},"ISSN":["0905-6157","1399-3038"],"issn-type":[{"value":"0905-6157","type":"print"},{"value":"1399-3038","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}